TLSI
NASDAQ · Biotechnology
Trisalus Life Sciences Inc
$4.75
+0.07 (+1.50%)
Open$4.74
Previous Close$4.68
Day High$4.88
Day Low$4.61
52W High$4.06
52W Low$1.97
Volume—
Avg Volume601.4K
Market Cap237.33M
P/E Ratio—
EPS$-0.49
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
-8.8% upside
Current
$4.75
$4.75
Target
$4.33
$4.33
$2.61
$4.33 avg
$5.56
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 47.23M | 45.65M | 46.65M |
| Net Income | -3,256,844 | -3,940,718 | -4,180,453 |
| Profit Margin | -6.9% | -8.6% | -9.0% |
| EBITDA | -4,196,050 | -4,663,249 | -4,114,414 |
| Free Cash Flow | -5,024,799 | -4,621,021 | -5,351,943 |
| Rev Growth | +7.1% | +0.6% | -1.0% |
| Debt/Equity | 1.07 | 0.92 | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |